" they" being the 3-4 constant FUDsters, who take every chance possible to trash the company.
obviously not shareholders.
notable posted 5 very clear, concise & accurate opportunities that Onc is very active with.
Regarding pharma " have data & should have made a move by now"
First, it was made quite clear in the CC. They have on- going discussions & the potential $$ pharma companies wanted to see the final results before further talks.
Moving to now , as in the last 2 months.
onc completed & published the Bracelet results, only a month ago.
it was also disc during the CC , " they have seen increased interest as a result of the final trial numbers,"
What, we do not know , if there has been any offers or movement towards offers.
Saying there " are none" , or " no pharma interest", is 100% conjecture.
Those thinking we will be informed of early stage discussions , need to be educated.
I have historically held a few companies that have been bought out.
To give context to my statement I'll name them.
chrysler, CIL industries, first city real fund, white rock REIT, Dofasco inc, Newfoundland telephone,
Hiram walker resourses. Corel technology.
That being over a 40+ yrs history of playing around in stocks.
Why, who cares? Well , I do have a bit of experience owning shares in companies being bought.
White rock reit being my most recent.
When the " deal" was made public,. Then & only then did the shaeholders get the information & whole picture.
In that package, was full disclosure of the negotiation process.
They described the first phone conference, involving a concept of a takeover. Giving us date & time if that call.
Followed by a sequence of meetings. First of which was a NDR.
offers, counter offers & a final agreed number.
THEN
Both sides had the numbers reviewed by outside lawyers & analysts , giving their opinion of " sensibilities" of the $$ being offered.
Then after all legal & financial items were covered , a trading hault, followed by the details of the offer , needing shareholders approval.
Giving I think, 30 days , for us to recieve a very bulky information package...scripting the negotiations, day by dat etc.
and the both sides outside opinion of the offer & management's recommendation to vote it in.
Again to provide context. The negotiations/ talks started October, the public announcement came I belive March. Meaning 6 months of talks, negotiations before shaeholders were notified.
it is 100% possible ONC is in talks. I can't say they are or are not.
Those who claim nothing so far etc etc. All we know for sure, there has been no finalized opportunity.
Regarding shaeholder approval etc. First city real fund was bought out by RioCan.
The management of first city presented the offer, however recommended it be voted down.
Riocan did up the ante about 10% , & that was accepted.
" insider information & people always know"
I was working @ Dofasco when it was bought out.
Not a peep of a takeover. All we knew was the SP was way underpriced.
So,.....claiming Onc has not been aquired , therfore never will be , is outright silly.
Dofasco for example,was around 75 yrs old when aquired.
Understand it or not, if when public traded companies are not properly priced, the following can happen.
1. The company will be bought out,
2. fundamentals will change , to justify the low SP.
3. The market , will recalibrate the trading price to match the fundamentals.
The analysts consensus is in the $5/ps range. Based on future value analysys of potential Pela sales.
discounted for both time & clinical risks.
Onc for the first time ever. Gave public disclosure of their calculations of potential Pela sales for the MBc market. Being $2.5 billion/ yr in sales. They have not yet discussed the Pancreatic or other G.I. Market opportunities.
and
They disclosed that is what is being presented as basis of negotiations.
That being a month ago.
Sorry for the long stories. However IMHO I feel it's important to qualify my opinions.
Imho Onc is way undervalued right now.
It's not because of the science, it is because of excruciating long processes.
The closure of PanCan for example. Was 100% outside of onc control.
That was a huge setback.
The alternative deal with CGAR is a great example of recovery. Sadly added months to the approval process.
i agree, 100%, The only way we will see proper value is in a buyout or partership.
evreryone knows that.
So, I'll wait.